Alpha- and beta-blockers reduce oxidative stress and inflammation caused by aircraft noise but fail to prevent hypertension, ...

The classification of drugs have been around since 1964 after Sir James Black discovered how they can assist people with ...

Aurelio Rojas Sanchez, a cardiologist based in Malaga, Spain, has warned that ibuprofen and other everyday medications can ...

The Supreme Court said Friday it will review the constitutionality of the Affordable Care Act’s no-cost coverage mandates for ...

Statins: For statins, the side effects can be surprising. Some people taking these medications have been found to gain weight ...

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

Cytokinetics' hopes of resurrecting cardiac myosin activator omecamtiv mecarbil have suffered another setback, after the drug failed to show a benefit in a phase 3 heart failure study.

The strong association between renal and cardiovascular disease makes recognition ... disease increases the potential need for multiple drug use and, therefore, the risk of adverse drug interactions.

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

Hutchmed, a biopharmaceutical company controlled by Hong Kong’s wealthiest person Li Ka-shing, is divesting a 45% stake in a ...

Metoprolol, acebutolol, and propranolol are heart medications linked to weight gain. Other heart medications may cause weight gain, but some might cause weight loss or be weight neutral.

a heart health company modernizing cardiovascular drug development, launched today with a mission to develop multiple targeted treatments in parallel, bringing people with cardiovascular diseases ...